Ingevity (NGVT) Accumulated Expenses (2015 - 2026)

Ingevity (NGVT) has reported Accumulated Expenses for 12 consecutive years, with $60.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses fell 60.01% year-over-year to $60.3 million; the TTM figure through Jun 2026 stood at $60.3 million (down 60.01% YoY), while the FY2025 annual figure was $148.0 million, up 154.73% from the prior year.
• Accumulated Expenses retreated to $60.3 million in Q2 2026 per NGVT's latest filing, from $165.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $165.0 million in Q1 2026 and bottomed at $44.8 million in Q2 2022.
• Historically, Accumulated Expenses has averaged $84.5 million across 5 years, with a median of $64.1 million in 2023.
• On a YoY basis, Accumulated Expenses climbed as much as 188.46% in 2026 and fell as far as 60.01% in 2026.
• Ingevity's Accumulated Expenses stood at $54.4 million in 2022, then soared by 32.9% to $72.3 million in 2023, then retreated by 19.64% to $58.1 million in 2024, then surged by 154.73% to $148.0 million in 2025, then slumped by 59.26% to $60.3 million in 2026.
• Business Quant data shows NGVT's Accumulated Expenses at $60.3 million in Q2 2026, $165.0 million in Q1 2026, and $148.0 million in Q4 2025.